Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-028362
Filing Date
2012-05-15
Accepted
2012-05-15 17:42:29
Documents
2
Period of Report
2012-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3884
2 POA DOCUMENT poa.txt EX-24.4_424269 3246
  Complete submission text file 0001209191-12-028362.txt   8583
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Issuer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMPAX LABORATORIES, INC. 121 NEW BRITAIN BLVD CHALFONT PA 18914
Business Address
KOCH ARTHUR A JR (Reporting) CIK: 0001240764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34263 | Film No.: 12846593